News and Trends 19 Aug 2022
Gilead to acquire remaining worldwide rights of breast cancer drug, Trodelvy
All of Everest Medicine's development and commercialization rights for a breast cancer drug called Trodelvy have been transferred to American biopharma Gilead Sciences Inc. The transfer of the antibody drug,…